FDA Approved: ZEPBOUND — Supplemental Application (Eli Lilly and Company)

View source ↗

Summary

FDA approved a supplemental application to expand ZEPBOUND's label for weight management in adults with obesity or overweight.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• ZEPBOUND (tirzepatide)

Snippet

SUPPL AP for ZEPBOUND (TIRZEPATIDE)